According to Swati Piramal, Vice Chairperson of Piramal Enterprises and director of Piramal Enterprises, India’s pharmaceutical sector has been declining – 17% just two years ago to 10% now. It is because of a number of problems other than India’s recently slowed down economy – clinical trials approved by the government in the country have reduced, and a number of other barriers block the way. Read more here.